1. Home
  2. ADUS vs AMPH Comparison

ADUS vs AMPH Comparison

Compare ADUS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$93.60

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$22.98

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
AMPH
Founded
1979
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.2B
IPO Year
2009
2005

Fundamental Metrics

Financial Performance
Metric
ADUS
AMPH
Price
$93.60
$22.98
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$135.40
$29.29
AVG Volume (30 Days)
209.1K
398.9K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
23.40
N/A
EPS
5.22
2.03
Revenue
N/A
$719,887,000.00
Revenue This Year
$9.17
$6.90
Revenue Next Year
$4.70
$4.64
P/E Ratio
$18.09
$11.27
Revenue Growth
N/A
N/A
52 Week Low
$90.89
$17.03
52 Week High
$124.44
$31.26

Technical Indicators

Market Signals
Indicator
ADUS
AMPH
Relative Strength Index (RSI) 40.46 65.98
Support Level N/A $20.41
Resistance Level $112.24 $29.30
Average True Range (ATR) 2.55 0.78
MACD 0.46 0.47
Stochastic Oscillator 51.82 92.98

Price Performance

Historical Comparison
ADUS
AMPH

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: